Cytodyn Inc (CYDY)

[Bored Lawyer]

I agree with your first point 100%. Respectfully I disagree with your second point. It is not the responsibility of you me, or any other investor to maintain the SP.

It is up to management to inspire enough confidence in investors that investors do not want to sell. On behalf of myself and many other long-time longs, management is failing badly in that regard - look no further than your first point.

It IS better to have no call if you have nothing to share. And yet, for 3+ years (at least), that lesson has gone unlearned. It's extraordinarily disappointing to me, and should be to all investors, because leronlimab deserves better. Too many patients, in too many indications, potentially could benefit.

Management impacts investor confidence. Investor confidence impacts SP. SP impacts ability to raise capital from reputable institutions on good terms and ability to uplist to NASDAQ (which should have happened years ago). Capital impacts ability to hire experts, open trial sites, enroll patients, and MOVE THE SCIENCE FORWARD TO APPROVAL.

I won't be selling tomorrow, because the SP will surely overreact, but management is losing the confidence of MANY long-time investors who own significant shares.